These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 388720)

  • 1. Evidence for the mechanism by which eicosapentaenoic acid inhibits human platelet aggregation and secretion - implications for the prevention of vascular disease.
    Jakubowski JA; Ardlie NG
    Thromb Res; 1979; 16(1-2):205-17. PubMed ID: 388720
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential inhibition of prostacyclin production and platelet aggregation by aspirin in humans.
    Masotti G; Galanti G; Poggesi L; Abbate R; Neri Serneri GG
    Adv Prostaglandin Thromboxane Res; 1980; 6():317-20. PubMed ID: 6992529
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of all cis-5,8,11,14,17 eicosapentaenoic acid and PGH3 on platelet aggregation.
    Gryglewski RJ; Salmon JA; Ubatuba FB; Weatherly BC; Moncada S; Vane JR
    Prostaglandins; 1979 Sep; 18(3):453-78. PubMed ID: 531220
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of acetylsalicylic acid on platelet aggregation before and during increase in dietary eicosapentaenoic acid.
    Thorngren M; Gustafson A; Wohlfart G
    Haemostasis; 1983; 13(4):244-7. PubMed ID: 6311694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism underlying the inhibition of platelet aggregation by eicosapentaenoic acid and its metabolites.
    Needleman P; Sprecher H; Whitaker MO; Wyche A
    Adv Prostaglandin Thromboxane Res; 1980; 6():61-8. PubMed ID: 6247894
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of 11-week increases in dietary eicosapentaenoic acid on bleeding time, lipids, and platelet aggregation.
    Thorngren M; Gustafson A
    Lancet; 1981 Nov; 2(8257):1190-3. PubMed ID: 6118628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihomo-gamma-linolenate suppresses platelet aggregation when administered in vitro or in vivo.
    Willis AL; Comai K; Kuhn DC; Paulsrud J
    Prostaglandins; 1974 Dec; 8(6):509-19. PubMed ID: 4462154
    [No Abstract]   [Full Text] [Related]  

  • 8. Dihomogammalinolenic acid (20:3 omega 6) is more anti-aggregatory than eicosapentaenoic (20:5 omega 3) in a platelet-endothelial cell mixture.
    Lagarde M; Burtin M; Dechavanne M; Sicard B; Coiffier B
    Prostaglandins Med; 1980 Mar; 4(3):177-83. PubMed ID: 6248913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of labile aggregation-stimulating substance (LASS) and platelet aggregation in diabetes mellitus.
    Colwell JA; Chambers A; Laimins M
    Diabetes; 1975 Jul; 24(7):684-7. PubMed ID: 1158034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eicosapentaenoic acid and platelet function in Japanese.
    Hirai A; Hamazaki T; Terano T; Nishikawa T; Tamura Y; Kamugai A; Jajiki J
    Lancet; 1980 Nov; 2(8204):1132-3. PubMed ID: 6107739
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of arachidonic- and eicosapentaenoic acid on the synthesis of prostacyclin-like material in human umbilical vasculature.
    Dyerberg J; Jørgensen KA
    Artery; 1980; 8(1):12-7. PubMed ID: 6252872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collagen-induced platelet aggregation: evidence of several mechanisms for the induction of platelet release by collagen.
    Nyman D
    Thromb Res; 1977 May; 10(5):743-51. PubMed ID: 882960
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of curcumin on platelet aggregation and vascular prostacyclin synthesis.
    Srivastava R; Puri V; Srimal RC; Dhawan BN
    Arzneimittelforschung; 1986 Apr; 36(4):715-7. PubMed ID: 3521617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of the oral administration of fish oil concentrate on the release and the metabolism of [14C]arachidonic acid and [14C]eicosapentaenoic acid by human platelets.
    Hirai A; Terano T; Hamazaki T; Sajiki J; Kondo S; Ozawa A; Fujita T; Miyamoto T; Tamura Y; Kumagai A
    Thromb Res; 1982 Nov; 28(3):285-98. PubMed ID: 6294902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An endoperoxide aggregator (Lass), formed in platelets in response to thrombotic stimuli: purification, identification and unique biological significance.
    Willis AL; Vane FM; Kuhn DC; Scott CG; Petrin M
    Prostaglandins; 1974 Dec; 8(6):453-507. PubMed ID: 4471695
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of dietary fatty acids, prostaglandins and related compounds on the role of platelets in thrombosis.
    Srivastava KC
    Biochem Exp Biol; 1980; 16(3):317-38. PubMed ID: 6268128
    [No Abstract]   [Full Text] [Related]  

  • 17. The fibrinogen-dependent pathway of platelet aggregation.
    Marguerie GA; Plow EF
    Ann N Y Acad Sci; 1983 Jun; 408():556-66. PubMed ID: 6307106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of platelet aggregation and thromboxane synthesis after intake of small amount of icosapentaenoic acid.
    Driss F; Vericel E; Lagarde M; Dechavanne M; Darcet P
    Thromb Res; 1984 Dec; 36(5):389-96. PubMed ID: 6098051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. All cis-5, 8, 11, 14, 17 eicosapentaenoic acid and triene prostaglandins: potential anti-thrombotic agents.
    Dyerberg J; Bang HO
    Scand J Clin Lab Invest; 1980; 40(7):589-93. PubMed ID: 6258218
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclic AMP-independent inhibition of human platelet function by eicosapentaenoic acid.
    Jakubowski JA; Ardlie NG
    Thromb Res; 1980 Mar; 17(5):751-2. PubMed ID: 6247778
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.